邵于宣(Shao, Yu-Hsuan) 教授

Email
jonishao@tmu.edu.tw
現   職
健康資料加值暨統計中心 主任
醫學資訊研究所 教授

學經歷

學 歷

畢業學校與學位[修業時間]
紐澤西醫學牙醫大學Epidemiology, SPH 博士
2003~2008
The Johns Hopkins UniversityFamily and Population Science 碩士
1998/09~2000/06
臺北醫學大學公共衛生學系 學士
1994/09~1998/06

本校學術經歷

任職單位與職稱[起迄時間]
醫學資訊研究所教授
2024/11/01~
大數據科技及管理研究所教授
2024/03/15~2024/10/31
醫學資訊研究所教授
2020/02/01~2024/03/14
醫學資訊研究所副教授
2014/02/01~2020/01/31
癌症研究中心(舊)顧問
2013/08/01~2014/01/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
大數據科技及管理研究所教授
2024/11/01 ~
醫學資訊研究所教授
2024/03/15 ~ 2024/10/31
健康資料加值暨統計中心主任
2022/08/01 ~
(舊)應用分子流行病學碩士學位學程副教授
2018/04/01 ~

其它經歷

任職單位與職稱[起迄時間]
UMDNJ, Robert Wood Johnson Medical SchoolAssistant Professor
2011/06~2013/07
The Cancer Institute of New JerseyResearch Associate
2009/11~2011/05

專長與研究領域

學門領域
學術專長
流行病學方法
流行病學方法
癌症流行病學
癌症流行病學
攝護腺癌
攝護腺癌
生物統計
生物統計

論文著作

清冊下載


1. 2024 Wang WH,Chiu FY,Kuo TZ,Shao YH. Maternal Prenatal Infections and Biliary Atresia in Offspring . JAMA Netw Open .2024

2. 2024 Yu-Hsuan Joni Shao,Chen WT, Yu SMW,Tsou LLA,Hsu YH,Wu MS, Kao YH, Chou CL, Hsiao PJ. Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan . Int J Med Sci .2024

3. 2024 Lin WY,Shao YJ,Chiang AF,Huang CC,Chiang KF,Chan CS, Huang CY, Hsiao BY. Long-Term Outcomes of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction and Coexisting End-Stage Renal Disease . Clin Pharmacol Ther .2024

4. 2024 Lee PH,Chen IC,Chen YM,Hsiao TH,Tseng JS,Huang YH, Hsu KH, Lin H, Yang TY, Shao YJ. Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan . JCO Precis Oncol. .2024

5. 2024 Shao, YH.J,Liao, CS.,Hsu, YC. et al.. Clinical relevance of protein-truncating variants of germline DNA repair genes in prostate cancer . BMC Cancer .2024

6. 2023 Su‑Chen Fang,Chia‑Chun Hung,Cheng‑Yi Huang,Sheng‑Miauh Huang,Yu-Hsuan Joni Shao. Influence of Baseline Psychiatric Disorders on Mortality and Suicide and Their Associations with Gender and Age in Patients with Methamphetamine Use Disorder . International Journal of Mental Health and Addiction .2023

7. 2023 Mandeep Garg,Vahid Karami,Javad Moazen,Thomas Kwee,Ashu Seith Bhalla,Daryoush Shahbazi-Gahrouei, Yu-Hsuan Joni Shao. Radiation Exposure and Lifetime Attributable Risk of Cancer Incidence and Mortality from Low- and Standard-Dose CT Chest: Implications for COVID-19 Pneumonia Subjects . Diagnostics .2023

8. 2023 Su-Chen Fang,Cheng-Yi Huang,Sheng-Miauh Huang,Yu-Hsuan Joni Shao. Associations and relative risks of pulmonary hypertension and lung diseases in patients with methamphetamine use disorder: a cohort study . Pulmonary .2023

9. 2023 Wei-Hao Wang,Chia-Yu Sung, Shih-Chung Wang,Yu-Hsuan Joni Shao. Risks of leukemia, intracranial tumours and lymphomas in childhood and early adulthood after pediatric radiation exposure from computed tomography . CMAJ .2023

10. 2023 Yu-Hsuan Joni Shao,Yi-Ming Chen. Parental autoimmunity and offspring risks of rheumatic diseases: a nationwide population-based study . Rheumatology. .2023

11. 2022 Yu-Chen Hou,Yu-Hsuan Joni Shao. The Effects of Statins on Prostate Cancer Patients Receiving Androgen Deprivation Therapy or Definitive Therapy: A Systematic Review and Meta-Analysis . Pharmaceuticals .2022

12. 2022 Su-Chen Fang,Cheng-Yi Huang,Yu-Hsuan Joni Shao. Long-Term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia . The Journal of Clinical Psychiatry .2022

13. 2022 Yu-Hsuan Joni Shao,Jian-Hua Hong, Chun-Kai Chen, Chao-Yuan Huang. Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan . Prostate Cancer and Prostatic Diseases .2022

14. 2021 Cheng-Yi Huang,Su-Chen Fang,Yu-Hsuan Joni Shao. Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia . JAMA Netw Open .2021

15. 2021 Ting-Hsuan Sun,Yu-Hsuan Joni Shao,Chien-Lin Mao,Miao-Neng Hung,Yi-Yun Lo,Tai-Ming Ko, Tzu-Hung Hsiao. A Novel Quality-Control Procedure to Improve the Accuracy of Rare Variant Calling in SNP Arrays . Front. Genet .2021

16. 2020 Wu SY,Fang SC,Hwang OR,Shih HJ,Shao YH. Influence of Baseline Cardiovascular Comorbidities on Mortality after Androgen Deprivation Therapy for Metastatic Prostate Cancer . Cancers .2020 ;(12)

17. 2020 Su‐Chen Fang,Ding‐Lieh Liao ,Cheng‐Yi Huang ,Chun‐Chi Hsu ,Shu‐Li Cheng ,Yu‐Hsuan J. Shao. The effectiveness of long‐acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophrenia . Human Psychopharmacology: Clinical and Experimental .2020

18. 2020 Shih H‐J,Fang S‐C,An L,Shao Y‐HJ. Early‐onset prostate cancer is associated with increased risks of disease progression and cancer‐specific mortality . The Prostate. .2020

19. 2019 Tzu-Hung Hsiao,Yu-Chiao Chiu,Yu-Hsuan Joni Shao. Multi-omics analysis reveals the BRCA1 mutation and mismatch repair gene signatures associated with survival, protein expression, and copy number alterations in prostate cancer . Transl Cancer Res .2019

20. 2019 Su-Chen Fang,Cheng-Yi Huang,Ding-Lieh Liao,Chun-Chi Hsu,Yu-Hsuan Joni Shao. Associations among antipsychotics, metabolism-related diseases, and cataracts in patients with schizophrenia: A retrospective cohort study . Schizophrenia Research .2019

21. 2019 Yu-Hsuan Shao,Kevin Tsai,Sinae Kim,Yu-Jen Wu,Kitaw Demissie. Exposure to Tomographic Scans and Cancer Risks. . JNCI Cancer Spectrum .2019

22. 2019 Szu-Yuan Wu,Su-Chen Fang,Hung-Jen Shih,Yu-Chin Wen,Yu-Hsuan Joni Shao. Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy . European Journal of Cancer .2019

23. 2018 Yu‐Hsuan Joni Shao,Szu‐Yuan Wu. Letter: association between proton pump inhibitors and the risk of hepatocellular carcinoma . Alimentary Pharmacology & Therapeutics .2018 ;(48):1165-1166

24. 2018 Yu-Hsuan Joni Shao,T.‐S. Chan,K. Tsai,S.‐Y. Wu. Association between proton pump inhibitors and the risk ofhepatocellular carcinoma . Aliment Pharmacol Ther .2018 ;(48):460-468

25. 2018 Yu‐Hsuan Joni Shao, Szu‐Yuan Wu. Letter: cohort study examining the association between proton pump inhibitors therapy and risk of hepatocellular carcinoma in Taiwan-authors' reply . Alimentary Pharmacology & Therapeutics .2018 ;(48):690-691

26. 2018 Amir Abbas KazemzadehFarizhandi,Adam Pacławski,Jakub Szlęk,Aleksander Mendyk,Yu-Hsuan Shao,Raymond Lau. Evaluation of carrier size and surface morphology in carrier-based dry powder inhalation by surrogate modeling Chemical Engineering Science . Chemical Engineering Science .2018 ;(193):144-155

27. 2018 scdNet: a computational tool for single-cell differential network analysis . BMC System Biology .2018

28. 2016 Chien Li-Nien ,Huang Yan Jiun ,Shao Yu-Hsuan ,Chang Chen Jung ,Chuang Ming Tsang . Proton pump inhibitors and risk of periampullary cancers - A nested case-control study . International Journal of Cancer .2016 ;(138):1401-1409

29. 2015 Zhang F,Ngoc, NT,Tay, BH,Mendyk A,Shao, YH,Lau, R. Roughness-Controlled Self-Assembly of Mannitol/LB Agar Microparticles by Polymorphic Transformation for Pulmonary Drug Delivery . Mol Pharm .2015 ;(12):223-231

30. 2015 Nguyen, TQN,Giam, HL,Wang, Y,Paclawski, A,Szlek, J,Mendyk, A, Shao, YH, Lau, R. Surface modification of pollen-shape carriers for dry powder inhalation through surface etching . Industrial & Engineering Chemistry Research .2015 ;(53):19943-19950

31. 2015 Joni Yu-Hsuan Shao,Fei-Peng Lee,Chia-Lun Chang,Szu-Yuan Wu. Statin-Based Palliative Therapy for Hepatocellular Carcinoma . Medicine .2015

32. 2014 Yu-Hsuan Shao,Sung Kim, Dirk F. Moore, Weichung Shih, Yong Lin, Mark Stein, Isaac Yi Kim, Grace L. Lu-Yao. Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis . Eur Urol .2014 ;(65):693-700

33. 2014 Chien LN,Lin HC,Shao YH,Chiou ST,Chiou HY. Risk of Autism Associated With General Anesthesia During Cesarean Delivery: A Population-Based Birth-Cohort Analysis . J Autism Dev Disorder .2014

34. 2013 Sung Kim,Dirk F Moore,Weichung Shih,Yong Lin,Hui Li,Yu-Hsuan Shao, Shunhua Shen, Grace L Lu-Yao. Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer—How Long Does it Last? . The Journal of Urology .2013

35. 2013 Yu-Hsuan Shao,Dirk F. Moore,Weichung Shih,Yong Lin,Thomas L. Jang,Grace L. Lu-Yao. Fracture after Androgen Deprivation Therapy among Men with a High Baseline Risk of Skeleton Complications . BJUI .2013 ;(111):745-752

36. 2013 Shao YH,Lu-Yao G. In regard to Shen et al . Int J Radiat Oncol Biol Phys .2013 ;(85):287-287

37. 2012 Matthew Dolan,Sung Kim,Yu-Hsuan Shao,Grace L. Lu-Yao. Authentication of Algorithm to Detect Metastases in Men with Prostate Cancer using ICD- 9 Codes. . Epidemiology Research International .2012

38. 2011 Shao YH,Lu-Yao G. Time to Rethink PSA Screening--Reply . Archives of Internal Medicine .2011 ;(171):595

39. 2011 Capurnyia B. Roberts,Peter C Albertsen,Yu-Hsuan Shao,Dirk F Moore, Amit Mehta, Mark Stein, Grace Lu-Yao. Patterns and correlates of prostate cancer treatment in older men . American Journal of Medicine .2011 ;(124):235-243

40. 2011 Sung Kim,Shunhua Shen,Dirk F. Moore, Weichung Shih, Yong Lin, Hui Li, Matthew Dolan, Yu-Hsuan Shao, Grace L. Lu-Yao. Late gastrointestinal toxicities following radiation therapy for prostate cancer . European Urology .2011 ;(60):908-916

41. 2011 Capurnyia B. Roberts,Thomas Jang,Yu-Hsuan Shao,Shamu Kabadi, Dirk F. Moore, Grace Lu-Yao. Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study. . Prostate and Prostatic Disease .2011 ;(14):313-319

42. 2011 Yu-Hsuan Shao,Peter C Albertsen, Weichung Shih, Calpurnyia Roberts, Grace Lu-Yao. The Impact of PSA Testing Frequency on Prostate Cancer Incidence and Treatment in Older Men . Prostate Cancer and Prostatic Diseases .2011 ;(14):332-339

43. 2010 Yu-Hsuan Shao,Peter C. Albertson,Calpurnyia B. Robert,Yong Lin,Amit R. Mehta,Mark N. Stein, Robert S. DiPaola, Grace L. Lu-Yao. Risk Profiles and Treatment Patterns among Men with Prostate Specific Antigen below 4 in the USA . Arch Intern Med .2010 ;(170):1256-1261

44. 2010 Yu-Hsuan Shao,Sherryl Croitor,Abel E. Moreyra,Alan C. Wilson,William J. Kostis,Nora M. Cosgrove, John B. Kostis. Comparison of Hospital versus Out-of-Hospital Coronary Death Rates in Women versus Men . Am J Cardiol .2010 ;(106):26-30

45. 2009 Yu-Hsuan Shao,Kitaw Demissie,Weichung Shih,Amit Mehta,Mark Stein,Calpurnyia Roberts, Robert DiPaola, Grace Lu-Yao. Contemporary risk profile of prostate cancer in the United States. . J Natl Cancer Inst .2009 ;(16):1280-1283

研究計畫

計畫名稱
113 探討罕見、不確定重要性與常見致病之基因變異對於前列腺癌風險與發病年齡之影響(3/3)
補助單位
國家科學及技術委員會

計畫名稱
113 延攬曹筱玫君參與「探討罕見、不確定重要性與常見致病之基因變異對於前列腺癌風險與發病年齡之影響」研究計畫案,申請本會補助,業經核定以「博士級研究人員」資格補助 (NSTC 113-2811-B-038-035)
補助單位
國家科學及技術委員會

計畫名稱
112 真性紅血球增多症病人治療狀況之回溯性研究計畫
補助單位
藥華醫藥股份有限公司

計畫名稱
112 探討罕見、不確定重要性與常見致病之基因變異對於前列腺癌風險與發病年齡之影響(2/3)
補助單位
國家科學及技術委員會

計畫名稱
112 「探討罕見、不確定重要性與常見致病之基因變異對於前列腺癌風險與發病年齡之影響」-劉淑萱君
補助單位
國家科學及技術委員會

計畫名稱
111 評估納入單基因與多基因變異對於抗核抗體(ANA)在全身性紅斑性狼瘡 (SLE)診斷的影響
補助單位
國家科學及技術委員會

計畫名稱
111 探討罕見、不確定重要性與常見致病之基因變異對於前列腺癌風險與發病年齡之影響(1/3)
補助單位
國家科學及技術委員會

計畫名稱
111 延攬劉淑萱君參與「探討罕見、不確定重要性與常見致病之基因變異對於前列腺癌風險與發病年齡之影響」研究計畫案
補助單位
國家科學及技術委員會

計畫名稱
109 The relationship between hormonal prostate cancer therapies and cardiovascular complications in Taiwanese population: a nationwide population-based cohort study
補助單位
輝凌藥品股份有限公司

計畫名稱
109 利用長期血液循環腫瘤DNA探討基因變異與前列腺癌復發風險與抗藥性以發展個人化醫療標記之研究
補助單位
科技部

計畫名稱
108 大學生對電子煙行銷感受度、知覺風險及使用行為研究
補助單位
科技部

計畫名稱
108 PEG-Intron 併用Ribavirin對於未接受干擾素治療感染C型肝炎病毒基因型第2型患者之真實世界證據
補助單位
藥華醫藥股份有限公司

計畫名稱
108 先天DNA修補基因突變與前列腺癌風險與癒後
補助單位
科技部

計畫名稱
106 探討前列腺癌病患接受去雄性激素療法之癒後及併發代謝症候群對於病程的影響與可能的藥物預防(3/3)
補助單位
科技部

計畫名稱
105 探討前列腺癌病患接受去雄性激素療法之癒後及併發代謝症候群對於病程的影響與可能的藥物預防(2/3)
補助單位
科技部

計畫名稱
105 探討前列腺癌病患接受去雄性激素療法之癒後及併發代謝症候群對於病程的影響與可能的藥物預防(2/3)
補助單位

計畫名稱
105 醫學資訊研究所碩士班研究生黃珞薇君擬於106年5月28日至5月29日赴日本東京(Tokyo)參加第19屆健康資訊管理與大數據國際會議
補助單位

計畫名稱
104 醫學資訊研究所邵于宣副教授擬於104年8月赴美國波士頓參加ISPE’s 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management ,申請補助所需費用一案
補助單位

計畫名稱
104 醫學資訊研究所邵于宣副教授擬於104年8月赴美國波士頓參加ISPE's 31st International conference on Pharmacoepidemiology & Therapeutic Risk Management
補助單位
科技部

計畫名稱
104 探討前列腺癌病患接受去雄性激素療法之癒後及併發代謝症候群對於病程的影響與可能的藥物預防(1/3)
補助單位
科技部

計畫名稱
104 探討前列腺癌病患接受去雄性激素療法之癒後及併發代謝症候群對於病程的影響與可能的藥物預防(1/3)
補助單位
科技部

計畫名稱
104 建立多構面癌症防治預測模式:以大腸癌為例-建立多構面癌症防治預測模式:以大腸癌為例
補助單位
科技部

計畫名稱
103 第17屆加斯坦歐洲衛生論壇
補助單位
行政院衛生署(更名衛生福利部)

計畫名稱
102 TMU102-AE1-B40
補助單位
臺北醫學大學新聘教師計畫